Owlet (NYSE:OWLT) Partners with Locus Health for Integrated Infant Health Monitoring

November 19, 2025 — Leads & Copy — Owlet, Inc. (NYSE: OWLT) has partnered with Locus Health to integrate infant health management by connecting data from Owlet’s FDA-cleared BabySat device directly into the Locus Health platform.

This collaboration gives healthcare providers ongoing and secure access to vital infant health information after hospital discharge, according to a press release.

Jonathan Harris, Owlet’s President and CEO, said that the transition from hospital to home represents both a challenge and a tremendous opportunity to improve outcomes for families and healthcare systems. He added that by integrating Owlet’s technology with Locus Health, the company is extending its mission beyond the nursery by connecting proven monitoring capabilities directly into clinical workflows and helping hospitals scale connected care while supporting families with confidence and continuity.

Each year, nearly 500,000 babies transition home from an ICU across the U.S., many with ongoing medical needs that require continued monitoring. This collaboration helps clinicians bridge that crucial gap between hospital and home, enabling more connected care for vulnerable infants. The integration supports monitoring of infants with complex conditions such as congenital heart defects, chronic lung disease, and arrhythmia management.

Andy Archer, Locus Health’s co-founder and CEO, said that the company’s outcomes-based solutions for populations like congenital heart disease and neonatal ICU patients will be further enhanced with a partner like Owlet. He added that the partnership will provide vital biometric data through the Locus platform to care teams that increasingly need both timely insights and enhanced workflow efficiency.

Providers using Locus Health will have access to patient data collected by BabySat, allowing them to remotely track key vital signs like oxygen saturation and pulse rate, help detect concerning trends early, and support timely intervention, all within the same clinical tools and workflows they already rely on. By delivering frequent, automated data updates, the integration eliminates manual data entry and minimizes the risk of transcription errors, with the goal of more accurate insights, better-informed clinical decisions, and improved outcomes, without adding workflow complexity for clinicians or burden on parents during what can be a very difficult time.

Dean Demitropoulos, Senior Director of Business Development at Owlet, said that Owlet has monitored more than 2.5 million babies, equipping parents and caregivers with clinically proven, reliable tools to track Baby’s key vitals. He added that the company’s growing footprint in the medical space, and collaboration with a pediatric market leader like Locus, underscores their vision to make health insights accessible at home for infants that require monitoring, bringing families and care teams together through connectivity.

For more information on Owlet’s products, including both FDA-cleared BabySat and Dream Sock®, visit www.owletcare.com. For more information on Locus Health’s product and platform solutions, visit www.locushealth.com.

About Owlet, Inc.

Owlet, Inc. (NYSE: OWLT), a leading pediatric health platform, is the only company in the world to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric monitors, delivering hospital-grade technology directly in the home. Our award-winning pediatric products and innovative software combine clinically tested monitoring systems, an integrated video platform, and a simple, easy-to-use app, providing parents with real-time health insights to stay informed on their child’s well-being, support restful sleep, and provide peace of mind anywhere. Since 2012, more than 2.5 million parents have trusted Owlet to monitor their children’s well-being and sleep. This adoption has fueled one of the largest collections of pediatric health and sleep data in the world, powering innovations that bridge the critical gap between hospital and home. Owlet is driving a new standard in pediatric wellness by pairing advanced medical technology with consumer-friendly design. Our mission is simple yet ambitious: to give every baby and every family the best possible start in life. Learn more at www.owletcare.com and follow us on LinkedIn and Instagram for company news and updates.

About Locus Health

Locus is making the promise of remote patient monitoring and electronic medical record integration a reality for a wide range of populations, supporting care teams’ ability to monitor patients and provide coordinated support. The Locus platform is used at many health systems across the US and in Canada, including multiple top Children’s Hospitals, and has been developed in part through a Small Business Innovation (SBIR) Award by the National Cancer Institute (NCI). For more information on our remote care management solution and to request a demo, visit www.locushealth.com.

Dean Demitropoulos, Senior Director of Business Development at Owlet.

Source: Owlet, Inc.

Source: Owlet, Inc.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.